» Articles » PMID: 28018446

Familial Mediterranean Fever Presenting As Fever of Unknown Origin in Korea

Overview
Specialty Pediatrics
Date 2016 Dec 27
PMID 28018446
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Familial Mediterranean fever (FMF) is the most common Mendelian autoinflammatory disease, characterized by uncontrolled activation of the innate immune system that manifests as recurrent brief fever and polyserositis (e.g., peritonitis, pleuritic, and arthritis). FMF is caused by autosomal recessive mutations of the Mediterranean fever gene, which encodes the pyrin protein. Although FMF predominantly affects people from Mediterranean and Middle Eastern ethnic origins, 3 cases of FMF have been reported in Korea since 2012. We report another case of FMF in Korea in which the patient presented with a month-long fever without serositis. After treatment with colchicine was initiated, the patient's symptoms quickly subsided. The response to colchicine was helpful for diagnosis. We compare the FMF genotypes in Korea with in other countries. Studying FMF cases in Korea will help establish the best exons to use for screening and diagnosis of Korean FMF.

Citing Articles

Comparative analysis of rare periodic fever syndromes including the first Korean case of hyperimmunoglobulinemia D and periodic fever syndrome.

Yoon Y, Kim H, Shim J, Lee J Clin Exp Pediatr. 2024; 67(10):550-552.

PMID: 39314199 PMC: 11471921. DOI: 10.3345/cep.2024.00787.


The Comparison of Pediatric Patients with Familial Mediterranean Fever Originated from Turkey and Crimea.

Kostik M, Akca Kaya U, Zhogova O, Sag E, Suspitsin E, Nizhnik V Turk Arch Pediatr. 2022; 57(5):551-557.

PMID: 36062443 PMC: 9524423. DOI: 10.5152/TurkArchPediatr.2022.22106.


Dimethylaminoparthenolide (DMAPT) as an alternative approach for treatment of Familial Mediterranean Fever (FMF).

Mosayebian A, Sherkat R, Abediankenari S, Golpour M, Rafiei A Iran J Basic Med Sci. 2022; 24(10):1421-1427.

PMID: 35096301 PMC: 8769508. DOI: 10.22038/IJBMS.2021.59180.13140.


Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review.

Tufan A, Lachmann H Turk J Med Sci. 2020; 50(SI-2):1591-1610.

PMID: 32806879 PMC: 7672358. DOI: 10.3906/sag-2008-11.

References
1.
Booty M, Chae J, Masters S, Remmers E, Barham B, Le J . Familial Mediterranean fever with a single MEFV mutation: where is the second hit?. Arthritis Rheum. 2009; 60(6):1851-61. PMC: 2753538. DOI: 10.1002/art.24569. View

2.
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T . Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997; 40(10):1879-85. DOI: 10.1002/art.1780401023. View

3.
Dundar M, Emirogullari E, Kiraz A, Taheri S, Baskol M . Common Familial Mediterranean Fever gene mutations in a Turkish cohort. Mol Biol Rep. 2010; 38(8):5065-9. DOI: 10.1007/s11033-010-0652-7. View

4.
Lainka E, Bielak M, Lohse P, Timmann C, Stojanov S, von Kries R . Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population. Eur J Pediatr. 2012; 171(12):1775-85. DOI: 10.1007/s00431-012-1803-8. View

5.
Lim A, Jang H, Han J, Song Y, Song W, Woo H . Familial Mediterranean fever: the first adult case in Korea. J Korean Med Sci. 2012; 27(11):1424-7. PMC: 3492681. DOI: 10.3346/jkms.2012.27.11.1424. View